Estradiol enantate (EEn or E2-EN), also spelled estradiol enanthate and sold under the brand names Perlutal and Topasel among others, is an
estrogen medication which is used in
hormonal birth control for women.
It is formulated in
combination with
dihydroxyprogesterone acetophenide (DHPA; algestone acetophenide), a
progestin
A progestogen, also referred to as a progestagen, gestagen, or gestogen, is a type of medication which produces effects similar to those of the natural product, natural female sex hormone progesterone in the body. A progestin is a ''synthetic co ...
, and is used specifically as a
combined injectable contraceptive.
Estradiol enantate is not available for medical use alone.
The medication, in combination with DHPA, is given by
injection into muscle
Intramuscular injection, often abbreviated IM, is the injection of a substance into a muscle. In medicine, it is one of several methods for parenteral administration of medications. Intramuscular injection may be preferred because muscles have l ...
once a month.
Side effects of estradiol enantate include
breast tenderness,
breast enlargement,
nausea,
headache
Headache is the symptom of pain in the face, head, or neck. It can occur as a migraine, tension-type headache, or cluster headache. There is an increased risk of depression in those with severe headaches.
Headaches can occur as a result ...
, and
fluid retention.
Estradiol enantate is an
estrogen and hence is an
agonist
An agonist is a chemical that activates a receptor to produce a biological response. Receptors are cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an antagonist blocks the action of the ago ...
of the
estrogen receptor, the
biological target of
estrogens like
estradiol.
It is an
estrogen ester and a long-lasting
prodrug
A prodrug is a medication or compound that, after intake, is metabolized (i.e., converted within the body) into a pharmacologically active drug. Instead of administering a drug directly, a corresponding prodrug can be used to improve how the drug ...
of
estradiol in the body.
Because of this, it is considered to be a
natural and
bioidentical form of estrogen.
Estradiol enantate was first described by 1954,
and was first studied in combination with DHPA as a combined injectable contraceptive in 1964.
The combination was introduced for clinical use by the mid-1970s.
Estradiol enantate is not available as a standalone medication (i.e., by itself without DHPA).
The combination is available in
Latin America and
Hong Kong, and was also previously marketed in
Spain and
Portugal.
Medical uses
Estradiol enantate is used in combination with the progestin DHPA as a once-monthly combined injectable contraceptive for women in
Latin America and
Hong Kong.
Estradiol enantate has been studied in
feminizing hormone therapy for transgender women as well.
The combination of estradiol enantate and DHPA has likewise been used by transgender women for such purposes.
Available forms
The following forms of estradiol enantate are or have been available for use:
* Estradiol enantate 10 mg and DHPA 150 mg (brand names Perlutal, Topasel, many others)
* Estradiol enantate 5 mg and DHPA 75 mg (brand names Anafertin, Patector NF, Yectames)
* Estradiol enantate 10 mg and DHPA 120 mg (brand names Unalmes, Yectuna)
* Estradiol enantate 10 mg and DHPA 75 mg (brand name Ova Repos; discontinued)
A 6 mg estradiol enantate and 90 mg DHPA formulation was also studied, but was never marketed.
The combination of estradiol enantate and DHPA has also been studied at other doses ranging from 5 to 50 mg estradiol enantate and 75 to 200 mg DHPA.
The combination of estradiol enantate and DHPA is provided in
ampoules at estradiol enantate concentrations of 5 mg/mL and 10 mg/mL.
Contraindications
Contraindications of estrogens include
coagulation problems,
cardiovascular disease
Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. CVD includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, h ...
s,
liver disease, and certain
hormone-sensitive cancers such as
breast cancer and
endometrial cancer
Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most o ...
, among others.
Side effects
The
side effects of estradiol enantate are the same as those of estradiol. Examples of such side effects include
breast tenderness and
enlargement,
nausea,
bloating,
edema
Edema, also spelled oedema, and also known as fluid retention, dropsy, hydropsy and swelling, is the build-up of fluid in the body's Tissue (biology), tissue. Most commonly, the legs or arms are affected. Symptoms may include skin which feels t ...
,
headache
Headache is the symptom of pain in the face, head, or neck. It can occur as a migraine, tension-type headache, or cluster headache. There is an increased risk of depression in those with severe headaches.
Headaches can occur as a result ...
, and
melasma.
The combination of estradiol enantate and DHPA as a combined injectable contraceptive has shown no adverse effects on
liver function,
lipid metabolism, or
coagulation.
A
Brazilian
case report of a
prolactinoma in a
transgender woman treated with 10 mg estradiol enantate every 2 weeks exists.
[Camara, V. L., Zanardi, U. V., Glezer, A., Paraiba, D. B., Bronstein, M. D., Mendonca, B. B., & Costa, E. M. F. (2010, June). Estrogen as a Presumed Risk Factor for Prolactinoma in a Male-to-Female Transsexual Patient. Endocrine Reviews, Supplement 1, 31(3), S347–S347. https://www.endocrine.org/-/media/endocrine/files/endo-annual-meetings/endo_abstracts_2010_02.pdf#page=347][Camara, V. L. (2010). Estradiol enantate First report of prolactinoma, in a transsexual. Reactions, 1311, 24. 10.2165/00128415-201013110-00077. https://link.springer.com/article/10.2165/00128415-201013110-00077] While
DHPA was not mentioned in this instance,
estradiol enantate is normally formulated in combination with DHPA including in Brazil.
Overdose
Symptom
Signs and symptoms are the observed or detectable signs, and experienced symptoms of an illness, injury, or condition. A sign for example may be a higher or lower temperature than normal, raised or lowered blood pressure or an abnormality showin ...
s of estrogen
overdosage may include
nausea,
vomiting,
bloating,
increased weight,
water retention,
breast tenderness,
vaginal discharge,
heavy legs, and
leg cramps
A cramp is a sudden, involuntary, painful skeletal muscle contraction or overshortening associated with electrical activity; while generally temporary and non-damaging, they can cause significant pain and a paralysis-like immobility of the aff ...
.
These side effects can be diminished by reducing the estrogen dosage.
Interactions
Inhibitor
Inhibitor or inhibition may refer to:
In biology
* Enzyme inhibitor, a substance that binds to an enzyme and decreases the enzyme's activity
* Reuptake inhibitor, a substance that increases neurotransmission by blocking the reuptake of a neurotra ...
s and
inducers of
cytochrome P450
Cytochromes P450 (CYPs) are a Protein superfamily, superfamily of enzymes containing heme as a cofactor (biochemistry), cofactor that functions as monooxygenases. In mammals, these proteins oxidize steroids, fatty acids, and xenobiotics, and are ...
may influence the
metabolism of estradiol and by extension circulating estradiol levels.
Pharmacology
Pharmacodynamics
Estradiol enantate is an
estradiol ester, or a
prodrug
A prodrug is a medication or compound that, after intake, is metabolized (i.e., converted within the body) into a pharmacologically active drug. Instead of administering a drug directly, a corresponding prodrug can be used to improve how the drug ...
of
estradiol.
As such, it is an
estrogen, or an
agonist
An agonist is a chemical that activates a receptor to produce a biological response. Receptors are cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an antagonist blocks the action of the ago ...
of the
estrogen receptors.
Estradiol enantate is of about 41% higher
molecular weight than estradiol due to the presence of its C17β
enantate
Enanthic acid, also called heptanoic acid, is an organic compound composed of a seven-carbon chain terminating in a carboxylic acid functional group. It is a colorless oily liquid with an unpleasant, rancid odor. It contributes to the odor of som ...
ester.
Because estradiol enantate is a prodrug of estradiol, it is considered to be a
natural and
bioidentical form of estrogen.
The combination of 10 mg estradiol enantate and 150 mg DHPA as a once-monthly combined injectable contraceptive (which achieves levels of estradiol of around 350 pg/mL)
has been found to have little to no effect on many markers of estrogen-modulated
liver protein synthesis, including circulating levels of
HDL and
LDL cholesterol,
copper,
ceruloplasmin, total and free
cortisol
Cortisol is a steroid hormone, in the glucocorticoid class of hormones. When used as a medication, it is known as hydrocortisone.
It is produced in many animals, mainly by the ''zona fasciculata'' of the adrenal cortex in the adrenal gland ...
,
corticosteroid-binding globulin, and
sex hormone-binding globulin.
However, it was found to significantly increase levels of
triglycerides and to significantly decrease levels of total and free
testosterone.
In contrast to the estradiol enantate-containing combined injectable contraceptive, low-dose
ethinylestradiol-containing
birth control pills produce highly significant changes in all of the preceding parameters.
Studies in women and female
capuchin monkeys have found that injections of estradiol enantate and DHPA significantly alter levels of
coagulation factors.
[Oliva Filho, W. M., & Santos, N. da C. (1992). Efeitos na coagulação sanguinea em usuárias da associação acetofenido de dihidroxiprogesterona 150mg e enantato de estradiol 10mg como metodo anticoncepcional injetavel. Universidade de São Paulo, São Paulo. https://bdpi.usp.br/item/000736190]
The clinical
estrogenic effects of estradiol enantate and
ethinylestradiol have been compared in other studies as well.
Pharmacokinetics
When estradiol enantate is administered in an
oil solution by
intramuscular injection
Intramuscular injection, often abbreviated IM, is the injection of a substance into a muscle. In medicine, it is one of several methods for parenteral administration of medications. Intramuscular injection may be preferred because muscles have ...
, a
depot effect occurs, and this results in it having a long
duration of action.
The duration of action of estradiol enantate is considerably longer than that of various other
estradiol esters, such as
estradiol benzoate,
estradiol valerate, and
estradiol cypionate, whereas its duration is shorter than that of
estradiol undecylate.
In general, the longer the
fatty acid ester
chain
A chain is a serial assembly of connected pieces, called links, typically made of metal, with an overall character similar to that of a rope in that it is flexible and curved in compression but linear, rigid, and load-bearing in tension. A c ...
, the more
lipophilic the estradiol ester, the more slowly it is released from the depot and absorbed into the circulation, and the longer its duration of action.
The
pharmacokinetics
Pharmacokinetics (from Ancient Greek ''pharmakon'' "drug" and ''kinetikos'' "moving, putting in motion"; see chemical kinetics), sometimes abbreviated as PK, is a branch of pharmacology dedicated to determining the fate of substances administered ...
of estradiol enantate have been assessed in a number of studies.
It has usually been studied in combination with DHPA.
Following an
intramuscular injection
Intramuscular injection, often abbreviated IM, is the injection of a substance into a muscle. In medicine, it is one of several methods for parenteral administration of medications. Intramuscular injection may be preferred because muscles have ...
of estradiol enantate, levels of estradiol have been found to peak after 3 to 8 days.
Maximal levels of estradiol after a 5 mg injection of estradiol enantate have been found to be about 163 to 209 pg/mL and after a 10 mg injection of estradiol enantate have been found to be about 283 to 445 pg/mL.
However, one outlying study reported peak estradiol levels of 850 pg/mL after an intramuscular injection of 10 mg estradiol enantate in three postmenopausal women.
It used
radioimmunoassay for the determinations, with no mention of
chromatographic separation
In chemical analysis, chromatography is a laboratory technique for the separation of a mixture into its components. The mixture is dissolved in a fluid solvent (gas or liquid) called the ''mobile phase'', which carries it through a system (a ...
.
Estradiol levels following an intramuscular injection of 10 mg estradiol enantate have been found to return to baseline levels of around 50 pg/mL after about 20 to 30 days.
However, a
metabolic
Metabolism (, from el, μεταβολή ''metabolē'', "change") is the set of life-sustaining chemical reactions in organisms. The three main functions of metabolism are: the conversion of the energy in food to energy available to run cell ...
study found that traces of
radiolabeled estradiol enantate remained detectable in blood for at least 30 to 40 days and for as long as 60 days.
Studies have reported that the
elimination half-life of estradiol enantate after a single 10 mg intramuscular injection was 5.6 to 7.5 days.
The
volume of distribution of estradiol enantate has been reported to be 5.087 L.
Estradiol enantate is
excreted preferentially in
urine.
There were concerns about possible accumulation of estradiol enantate and consequent estrogenic overexposure with once-monthly combined injectable contraceptives containing the medication due its long
duration, and this may have limited the use of such combined injectable contraceptives.
Subsequent clinical studies have found that there is very limited or no accumulation of estradiol enantate when it is used in once-a-month injectable contraceptives.
Chemistry
Estradiol enantate, also known as estradiol 17β-enantate or estra-1,3,5(10)-triene-3,17β-diol 17β-heptanoate, is a
synthetic Synthetic things are composed of multiple parts, often with the implication that they are artificial. In particular, 'synthetic' may refer to:
Science
* Synthetic chemical or compound, produced by the process of chemical synthesis
* Synthetic o ...
estrane steroid
A steroid is a biologically active organic compound with four rings arranged in a specific molecular configuration. Steroids have two principal biological functions: as important components of cell membranes that alter membrane fluidity; and a ...
and the C17β
enantate
Enanthic acid, also called heptanoic acid, is an organic compound composed of a seven-carbon chain terminating in a carboxylic acid functional group. It is a colorless oily liquid with an unpleasant, rancid odor. It contributes to the odor of som ...
(heptanoate)
fatty acid ester of
estradiol.
Other common esters of estradiol used clinically include
estradiol benzoate,
estradiol cypionate,
estradiol undecylate, and
estradiol valerate.
Estradiol dienantate (component of
Climacteron), or estradiol 3,17β-dienantate, has also been used.
The experimental
octanol/water partition coefficient (logP) of estradiol enanthate is 6.7.
History
Estradiol enantate was first described, along with a variety of other
estradiol esters, by Karl Junkmann of
Schering AG in 1953.
The first clinical study of estradiol enantate and DHPA as a
combined injectable contraceptive was conducted in 1964.
The combination was marketed by the mid-1970s.
Society and culture
Generic names
''Estradiol enantate'' is the
British English generic name of the medication and its and , while ''estradiol enanthate'' is its and
American English
American English, sometimes called United States English or U.S. English, is the set of variety (linguistics), varieties of the English language native to the United States. English is the Languages of the United States, most widely spoken lan ...
generic name.
Its generic names in other languages are as follows:
*
French
French (french: français(e), link=no) may refer to:
* Something of, from, or related to France
** French language, which originated in France, and its various dialects and accents
** French people, a nation and ethnic group identified with Franc ...
: ''enantate d'estradiol'' and ''estradiol enantate''
*
German: ''estradiol enantat''
*
Italian: ''estradiolo enantato''
*
Portuguese and
Spanish: ''enantato de estradiol'' and ''estradiol enantato''
Estradiol enantate is also known by its former developmental code name ''SQ-16150''.
It has been referred to as ''estradiol heptanoate''.
Brand names
Estradiol enantate has been marketed under a wide variety of brand names.
It has been marketed in a few different preparations, with varying doses of estradiol enantate and DHPA.
These formulations all have different brand names, which include the following (
† = discontinued):
* EEn 10 mg / DHPA 150 mg: Acefil, Agurin
†, Atrimon
†, Ciclomes, Ciclovar, Ciclovular, Cicnor
†, Clinomin, Cycloven, Daiva, Damix, Deprans, Deproxone, Exuna, Ginestest, Ginoplan
†, Gynomes, Horprotal, Listen, Luvonal, Neogestar, Neolutin, Nomagest, Nonestrol, Normagest, Normensil, Novular, Oterol, Ovoginal, Patector, Patectro, Perludil, Perlumes, Perlutal, Perlutale, Perlutan, Perlutin, Perlutin-Unifarma, Permisil, Preg-Less, Pregnolan, Progestrol
†, Protegin, Proter, Seguralmes, Synovular, Topasel, Unigalen, Uno-Ciclo, and Vagital.
* EEn 10 mg / DHPA 120 mg: Anafertin
†, Patector NF, and Yectames.
* EEn 5 mg / DHPA 75 mg: Unalmes and Yectuna.
* EEn 10 mg / DHPA 75 mg: Ova Repos
†.
* Unsorted: Evitas
†, Femineo
†, and Primyfar
†.
The combination of EEn 10 mg and DHPA 150 mg was developed under the developmental brand name Deladroxate, but this brand name was never used commercially.
Availability

Estradiol enantate has been marketed in combination with DHPA as a
combined injectable contraceptive in at least 19 countries, mostly in
Latin America.
/ref> A few different preparations, with varying doses of EEn and DHPA and varying availability, have been introduced. These formulations have the following approval and availability († = discontinued in this country):
* EEn 10 mg / DHPA 150 mg: at least 19 countries, including Argentina, Belize, Brazil, Chile, Colombia
Colombia (, ; ), officially the Republic of Colombia, is a country in South America with insular regions in North America—near Nicaragua's Caribbean coast—as well as in the Pacific Ocean. The Colombian mainland is bordered by the Car ...
, Costa Rica
Costa Rica (, ; ; literally "Rich Coast"), officially the Republic of Costa Rica ( es, República de Costa Rica), is a country in the Central American region of North America, bordered by Nicaragua to the north, the Caribbean Sea to the no ...
, the Dominican Republic, Ecuador, El Salvador
El Salvador (; , meaning " The Saviour"), officially the Republic of El Salvador ( es, República de El Salvador), is a country in Central America. It is bordered on the northeast by Honduras, on the northwest by Guatemala, and on the south b ...
, Guatemala
Guatemala ( ; ), officially the Republic of Guatemala ( es, República de Guatemala, links=no), is a country in Central America. It is bordered to the north and west by Mexico; to the northeast by Belize and the Caribbean; to the east by H ...
, Honduras
Honduras, officially the Republic of Honduras, is a country in Central America. The republic of Honduras is bordered to the west by Guatemala, to the southwest by El Salvador, to the southeast by Nicaragua, to the south by the Pacific Oce ...
, Hong Kong, Mexico, Nicaragua, Panama, Paraguay, Peru, Portugal†, and Spain†.
* EEn 10 mg / DHPA 120 mg: at least 3 countries, including Brazil†, Chile, and Paraguay.
* EEn 5 mg / DHPA 75 mg: at least 9 countries, including Costa Rica
Costa Rica (, ; ; literally "Rich Coast"), officially the Republic of Costa Rica ( es, República de Costa Rica), is a country in the Central American region of North America, bordered by Nicaragua to the north, the Caribbean Sea to the no ...
, the Dominican Republic, El Salvador
El Salvador (; , meaning " The Saviour"), officially the Republic of El Salvador ( es, República de El Salvador), is a country in Central America. It is bordered on the northeast by Honduras, on the northwest by Guatemala, and on the south b ...
, Guatemala
Guatemala ( ; ), officially the Republic of Guatemala ( es, República de Guatemala, links=no), is a country in Central America. It is bordered to the north and west by Mexico; to the northeast by Belize and the Caribbean; to the east by H ...
, Honduras
Honduras, officially the Republic of Honduras, is a country in Central America. The republic of Honduras is bordered to the west by Guatemala, to the southwest by El Salvador, to the southeast by Nicaragua, to the south by the Pacific Oce ...
, Mexico, Nicaragua, Panama, and Spain†.
EEn is also available in Canada in combination with estradiol benzoate and testosterone enantate for veterinary use as Uni-Bol.
Usage
EEn/DHPA is the most widely used combined injectable contraceptive in Latin America. It was estimated in 1995 that EEn/DHPA was used as a combined injectable contraceptive in Latin America by at least 1 million women. However, combined injectable contraceptives like EEn/DHPA are unlikely to constitute a large proportion of total contraceptive use in the countries in which they are available.
See also
* Estradiol enantate/algestone acetophenide
* Estradiol/estradiol enanthate
References
{{Estrogen receptor modulators
Antigonadotropins
Enanthate esters
Estradiol esters
Hormonal contraception
Phenols
Prodrugs
Synthetic estrogens
Veterinary drugs